Stroke Victims and Botox | DermaNetwork.org


Top Procedures BOTOX® Chemical Peels Fotofacial / IPL Fraxel JUVEDERM® LATISSE® Mesotherapy Restylane Smart Lipo VelaShape
Skin Conditions Acne Acne Scars Age Spots Cellulite Eczema Facial Veins Fine Lines & Wrinkles Freckles Liver Spots Melanoma Melasma Moles Psoriasis Rosacea Sun Spots Vitiligo Laser Liposuction Cool Lipo Laser Liposuction Lipolite Laser Liposculpture Lipotherme ProLipo PureLipo Slim Lipo Smart Lipo Smartlipo MPX SmoothLipo Vaser Liposelection Zerona Laser Liposuction Body Contouring Accent XL Aluma Body Jet Liposuction CoolSculpting LipoDissolve Mesotherapy Refirme Thermacool Thermage® Titan® Injectables & Fillers ArteFill Belotero Balance BOTOX® Captique Collagen Cosmoplast/Cosmoderm Dermal Fillers Dysport Elevess Evolence Hylaform® JUVEDERM® Lip Enhancement Perlane Prevelle Silk Purtox Radiesse™ Restylane® Sculptra™ Vitrase Acne Scar Treatments Blue Light Smoothbeam Anti-Aging Treatments Epidermal Leveling FotoFacial™/IPL Treatments Genesis Skin Rejuvenation Liquid Facelift Pelleve Revlite Rejuvenation Skin Tyte Threadlift Triniti Cellulite Treatments Acoustic Wave Therapy SmoothShapes TriActive Velashape VelaSmooth Fractional Resurfacing Active FX Deep FX Fractional Resurfacing Fractional Resurfacing Fraxel Fraxel re:pair Fraxel re:store Laser Resurfacing Palomar 1540 Fractional Resurfacing Palomar Fractional Resurfacing Profractional Resurfacing SmartXide Dot Therapy Cosmetic Enhancement Acne Treatment Blue Peel Chemical Peels Cosmelan Dermabrasion Hyperhidrosis BOTOX® Treatment Isolaz Laser 360 Laser Hair Removal Laser Tattoo Removal LATISSE® Microdermabrasion Photodynamic Therapy Skin Care & Cosmetic Products Skin Rejuvenation Sunless Tanning VI Peel Vitalize Peel
Training Courses For Physicians Email A Friend This Page Insurance Info Resources Skin Care Information Testimonials

Home

About Us

FAQs

Blog Home –› Stroke Victims and Botox

Stroke Victims and Botox

The FDA has approved Dysport the Botox rival in wrinkle-removal, however the
FDA has delayed approving Botox injections for upper limb spasticity. Allergen
hopes that Botox-use for non-cosmetic ailments will soon surpass its
cosmetic use in profits. However surpassing the $1 billion a year sales in
cosmetic use for Botox seems shocking especially as we are in the midst of a
downturn.

Reuters said, "It is also counting on neurology uses for Botox to help shore
up cosmetic sales that have been hit hard by the recession. Allergen said
the FDA indicated it must first review the company's proposed Risk
Evaluation and Mitigation Strategy for the medicine before approving it for
the movement disorder common to stroke sufferers."

The FDA has asked Allergen for complete documentation and evidence from its
clinical studies for therapeutic use of Botox. If the FDA did approve the
use of Botox for spasticity, it would be a huge boost for Allergen, as the
recession has adversely affected its cosmetic sales.

Posted by Tala on 5/28/2009 3:45:59 PM

Most Recent Posts

Top Cities for Smart Lipo

More Cities

PHYSICIANS LIST YOUR PRACTICE

Copyright © 2012 HealthNews.org. All Rights Reserved. Do not use this website as a substitute for medical care. Please consult your physician or other medical care provider regarding any medical questions you may have.

DermaNetwork is an informational site to find doctors & specialists dealing with awareness, problems, treatments, and costs associated with skin care.

Most Recent Posts

Previous Posts